mopidamol has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gastpar, H | 1 |
| Calman, KC; Gracie, A; Malcolm, A; McLeod, T; Willmott, N | 1 |
1 review(s) available for mopidamol and Lymphoma
| Article | Year |
|---|---|
Platelet aggregation inhibitors and cancer metastasis.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Carcinoma 256, Walker; Cyclic AMP; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neuraminidase; Platelet Aggregation; Rabbits; Rats; Sarcoma; Vasodilator Agents | 1982 |
1 other study(ies) available for mopidamol and Lymphoma
| Article | Year |
|---|---|
Changes in anatomical distribution of tumour lesions induced by platelet-active drugs.
Topics: Animals; Bacterial Infections; Blood Platelets; Female; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred CBA; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Propionibacterium acnes; Sarcoma 180; Thrombocytopenia; Thrombosis | 1983 |